RegisterLogin

CDK9-IN-37

CAT: 0931-T207214-01Size: 10 mgDry Ice: NoHazardous: No
CAT#:0931-T207214-01Size:10 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Target
CDK
Related Pathways
Cell Cycle/Checkpoint
Bioactivity
CDK9-IN-37 (Compound 24) is a CDK9 inhibitor with high selectivity, demonstrating an EC50 of 5.5 nM and minimal inhibition of other CDK subtypes. It shows significant antiproliferative activity against acute myeloid leukemia cells MOLM-13, with an IC50 of 0.034 ?M. CDK9-IN-37 suppresses CDK9 signaling, reducing RNAP II CTD (Ser2) phosphorylation, downregulating the anti-apoptotic protein McI-1, inducing apoptosis, and causing cell cycle arrest at the G2/M phase. This compound is applicable in the research of acute myeloid leukemia (AML) .
Molecular Formula
C20H19FN2O4S2
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Related Products

CatalogName
T204836-01CDK2-IN-37
T39354-01CDK9-IN-12
T10741CDK9-IN-1
T211204-01CDK9-IN-39
T9632-01CDK9-IN-30
T82757-01CDK9-IN-29
T14918-01CDK9-IN-2
T10747CDK9-IN-9
T79354-01CDK9-IN-24
T79367-01CDK9-IN-27

Alternative Products

CatalogName
HY-173481CDK9-IN-37
521355-01CDK9
MBS8529280-01CDK9 Antibody
MBS3614751-01CDK9-IN-10
M11131-01CDK9-IN-2
M35446-01CDK9-IN-15
M13368-01CDK9-PROTAC
310257CDK9 discontinued
AF4740-BPCDK9 Peptide
MBS5821029CDK9-IN-27

Popular Products